The Latest: Court reconvenes for hearing on militia leader - Fox News

-

ALBUQUERQUE, N.M. – The Latest on legal proceedings against the leader of an armed group that detained migrants near Mexican border(all times local):

2:35 p.m.

A federal court hearing has reconvened after an evacuation in legal proceedings against the leader of an armed group that detained immigrants at the U.S. border with Mexico.

Attorneys and court officials returned Monday to a hearing for Larry Mitchell Hopkins, who is being held on a weapons charge, after the courtroom was cleared without explanation by the U.S. Marshals Service.

The charge stems from a 2017 visit by an FBI agent to his home in New Mexico.

His arrest on April 20 followed widespread criticism after videos surfaced of members of the United Constitutional Patriots carrying firearms and detaining groups of immigrants crossing the border.

___

Noon:

A federal courthouse has been evacuated ahead of a hearing for the leader of an armed group that detained asylum-seeking families near the U.S.-Mexico border.

The U.S. Marshals Service said it could not immediately provide information on why the courthouse had been cleared Monday. Attorneys and court officials exited and gathered in front of the courthouse in Albuquerque.

Larry Mitchell Hopkins, the militia leader who has been indicted on a weapons charge, was escorted out of the courtroom where he had been waiting to appear before a magistrate judge for a detention hearing.

He faces weapons charges stemming from a 2017 visit by an FBI agent to his home in northwestern New Mexico.

He was arrested April 20 in Sunland Park, New Mexico.



https://fxn.ws/2Wfstnh

Comments

Post a Comment

Popular posts from this blog

Well-liked Medicare plan vs. higher-ranked providers - ChicagoNow

-
Image
Medicare Open Enrollment ends December 7. The easy choice is to stay with all-in-one Medicare Advantage instead of switching to Traditional Medicare plus a supplement and drug plan. The hard one is whether to switch between Medicare Advantage plans, from a well-liked one to one accepted at a so-called top-10 hospital. Humana Gold Plus, a Medicare Advantage HMO, has served me well for five years. Hearing aids cost me only $10 after its $2,000 allowance. Routine doctor and dentist appointments and my medication cost nothing. But Humana Gold Plus is not accepted by Northwestern Memorial Hospital, the nearby hospital that US News & World Report ranks as the tenth best in the country, or by Northwestern Medicine physicians. My primary care physician is in an Advocate Medical Group. If I were hospitalized, it would be at Advocate Illinois Masonic Medical Center. If I had a serious illness, I’d see specialists in Advocate’s network. Illinois Masonic is not a second-rate hospital, and
Read more

Minnesota veterans blame 3M's 'defective' ear plugs for hearing damage - KSTP

-
Image
3M did not admit any wrongdoing as part of that settlement. Read 3M's full statement on the ear plugs here. "We deny this product was defectively designed," a company spokesperson said in a statement to 5 INVESTIGATES, adding they will "defend against the allegations in these lawsuits." More than 630 lawsuits have been filed and will be heard in a federal court in Florida. An attorney involved with the multi-district litigation says roughly 30 have been filed by veterans who live in Minnesota. Constant ringing Sarah Kay Carlson, an Army veteran from St. Paul, filed her lawsuit in April, claiming 3M exposed her and thousands of other Marines and soldiers to "extremely dangerous and disabling noise." 3M Earplug Complaint (Sarah Kay Carlson) Ramsey County (Filed) (PDF) 3M Earplug Complaint (Sarah Kay Carlson) Ramsey County (Filed) (Text) Carlson, who was deployed as part of Operation Iraqi Freedom in the late 2000s, provided security to convoys t
Read more

Sickle Cell Disease (SCD): Practice Essentials, Background, Genetics

-
Image
hemophilia c factor 11 :: Article Creator Regeneron Reports Fourth Quarter And Full Year 2023 Financial And Operating Results Fourth quarter 2023 revenues increased 1% to $3.43 billion versus fourth quarter 2022; excluding RonapreveTM(a)(b), revenuesincreased 14% Full year 2023 revenues increased 8% to $13.12 billion versus full year 2022;excluding Ronapreve(a), revenuesincreased 12% Fourth quarter 2023 Dupixent®global net sales(recorded by Sanofi) increased 31% to $3.22 billion versus fourth quarter 2022; full year 2023 Dupixent global net sales increased 33% to $11.59 billion versus 2022 Fourth quarter 2023 U.S. Net sales for EYLEA®HD and EYLEA®were $1.46 billion, including $123 million from EYLEA HD; full year 2023 U.S. Net sales for EYLEA HD and EYLEA were $5.89 billion, including $166 million from EYLEA HD following its August 2023 FDA approval Fourth quarter 2023 Libtayo®global n
Read more